Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations

International Journal of Radiation Oncology, Biology, Physics

Volumn 18, Issue 5, 1990, Pages 1043-1050

  Wong, Ka Ho ^a   Wallen, C Anne ^a   Wheeler, Kenneth T ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

2 nitroimidazoles; Chemosensitization; Nitrosoureas; Pharmacokinetics; sc 9L tumors

Indexed keywords

CARMUSTINE; ETANIDAZOLE; LOMUSTINE; MISONIDAZOLE;

ARTICLE; BIOLOGICAL MODEL; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CARMUSTINE; DRUG SYNERGISM; ETANIDAZOLE; LOMUSTINE; MALE; MISONIDAZOLE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; NITROSOUREA COMPOUNDS; RATS; RATS, INBRED F344; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025329333     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(90)90439-Q     Document Type: Article

References (29)

1. SR2508 a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
2. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells
3. The measurement of oxygenation status of individual tumors
4. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR-2508 and the pharmacokinetic profile
5. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
6. Effect of partition coefficient on the ability of nitroimidazole to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea
7. Modification of CCNU pharmacokinetics by misonidazole-a major mechanism of chemosensitization in mice
8. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain
9. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics
10. The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice
11. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro
12. Update: the potential for chemosensitization of alkylating agents by nitroimidazoles
13. Clinical chemosensitization by misonidazole and related compounds; a critical evaluation
14. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice
15. Factors associated with the preincubation effect of hypoxic cell sensitizers in vitro and their possible implications in chemosensitization
16. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers
17. Modification of chemotherapy by nitroimidazoles
18. Enhanced tumor responses through therapies combining CCNU, MISO and radiation
19. Sensitization of cancer chemotherapeutic agents by nitroheterocyclics
20. In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole
21. 3H]misonidazole in the perfused rat liver
22. 3H]misonidazole by hypoxic rat liver
23. Glutathione depletion by 2-nitroimidazole-l-acetehydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes
24. Pharmacokinetic interaction of BCNU and misonidazole in human
25. Evidence of an unconventional radiosensitivity of 9L subcutaneous tumors
26. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole
27. The concept of drug dose for in vitro studies with chemotherapeutic agents
28. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L sub cutaneous tumors
29. Drug metabolism and chemosensitization: nitroimidazoles as inhibitors of drug metabolism